Rózycka Agata, Trzeciak Wiesław H
Department of Biochemistry and Molecular Biology, K. Marcinkowski University of Medical Sciences, ul. Swiecickiego 6, 60-781 Pozná, Poland.
J Appl Genet. 2003;44(2):197-207.
In this review the current literature regarding autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is presented and discussed. This disease is caused by mutations of genes coding for subunits of neuronal acetylcholine receptor comprising the sodium/potassium ion channel. To date, three types of mutations of the gene encoding alpha4 subunit of acetylcholine receptor were described in multi-generation families in Australia, Spain, Norway and Japan. Two other types of mutations of the beta2 subunit were also reported in two families, one from Italy and the other from Scotland. Mutations were caused by substitutions of a single nucleotide or by several-nucleotide insertions and result in a decrease or an increase in the activity of the receptor, or its changes in the affinity to the ligand. Recent advances in molecular genetics have provided the means for a better understanding of human epileptogenesis at a molecular level, which facilitates clinical diagnosis and provides a more rational basis of therapy of this form of epilepsy.
在本综述中,我们呈现并讨论了关于常染色体显性遗传性夜间额叶癫痫(ADNFLE)的当前文献。该疾病由编码包含钠/钾离子通道的神经元乙酰胆碱受体亚基的基因突变引起。迄今为止,在澳大利亚、西班牙、挪威和日本的多代家族中描述了乙酰胆碱受体α4亚基编码基因的三种突变类型。在另外两个家族中也报道了β2亚基的另外两种突变类型,一个家族来自意大利,另一个来自苏格兰。突变是由单个核苷酸的替换或几个核苷酸的插入引起的,导致受体活性降低或增加,或其对配体的亲和力发生变化。分子遗传学的最新进展为在分子水平上更好地理解人类癫痫发生提供了手段,这有助于临床诊断,并为这种形式的癫痫治疗提供了更合理的基础。